| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancer
|
Han, Boram
|
|
2016
|
78 |
5 |
p. 949-958
|
artikel
|
| 2 |
A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma
|
Ibata, Soushi
|
|
2016
|
78 |
5 |
p. 1041-1049
|
artikel
|
| 3 |
A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors
|
Bailey, Hanna
|
|
2016
|
78 |
5 |
p. 1059-1071
|
artikel
|
| 4 |
15-0600-Dr. Fox’s response to letter to the editor
|
Fox, Elizabeth
|
|
2016
|
78 |
5 |
p. 1099-1100
|
artikel
|
| 5 |
Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients
|
Forster, Victoria J.
|
|
2016
|
78 |
5 |
p. 1093-1096
|
artikel
|
| 6 |
Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study
|
Munasinghe, Wijith
|
|
2016
|
78 |
5 |
p. 1003-1011
|
artikel
|
| 7 |
Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
|
Edelman, Martin J.
|
|
2016
|
78 |
5 |
p. 969
|
artikel
|
| 8 |
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
|
Ribeiro, Ronaldo A.
|
|
2016
|
78 |
5 |
p. 881-893
|
artikel
|
| 9 |
JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo
|
Wang, Cong
|
|
2016
|
78 |
5 |
p. 971-982
|
artikel
|
| 10 |
Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas
|
Nathenson, Michael J.
|
|
2016
|
78 |
5 |
p. 895-919
|
artikel
|
| 11 |
Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia
|
Nielsen, Stine Nygaard
|
|
2016
|
78 |
5 |
p. 983-994
|
artikel
|
| 12 |
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
|
Edelman, Martin J.
|
|
2016
|
78 |
5 |
p. 959-967
|
artikel
|
| 13 |
Phase I study of the second-generation, recombinant, human EGFR antibody necitumumab in Japanese patients with advanced solid tumors
|
Tamura, Yosuke
|
|
2016
|
78 |
5 |
p. 995-1002
|
artikel
|
| 14 |
Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment
|
Kelly, Kevin R.
|
|
2016
|
78 |
5 |
p. 929-939
|
artikel
|
| 15 |
Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer
|
Fukae, Masato
|
|
2016
|
78 |
5 |
p. 1013-1023
|
artikel
|
| 16 |
Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia
|
Varatharajan, Savitha
|
|
2016
|
78 |
5 |
p. 1051-1058
|
artikel
|
| 17 |
Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats
|
Iarkov, Alexandre
|
|
2016
|
78 |
5 |
p. 1033-1039
|
artikel
|
| 18 |
Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience
|
Oda, Naohiro
|
|
|
78 |
5 |
p. 941-947
|
artikel
|
| 19 |
Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience
|
Oda, Naohiro
|
|
2016
|
78 |
5 |
p. 941-947
|
artikel
|
| 20 |
Progranulin as a predictive factor of response to chemotherapy in advanced biliary tract carcinoma
|
Kim, Jong-Ho
|
|
2016
|
78 |
5 |
p. 1085-1092
|
artikel
|
| 21 |
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors
|
Sarantopoulos, John
|
|
2016
|
78 |
5 |
p. 921-927
|
artikel
|
| 22 |
Synthesis of polydopamine as a new and biocompatible coating of magnetic nanoparticles for delivery of doxorubicin in mouse breast adenocarcinoma
|
Zavareh, Saeed
|
|
2016
|
78 |
5 |
p. 1073-1084
|
artikel
|
| 23 |
The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells
|
Wang, Xu
|
|
2016
|
78 |
5 |
p. 1025-1031
|
artikel
|
| 24 |
Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
|
Srinivas, Nuggehally R.
|
|
2016
|
78 |
5 |
p. 1097-1098
|
artikel
|
Tijdschrift beschrijving